Bifogade filer
Kurs & Likviditet
Prenumeration
Du har en aktiv prenumeration.
Prenumerera på pressmeddelanden från Nanexa via email.
Du prenumererar på följande språk.
Välj vilka språk du vill prenumerera på.
Modular Finance AB kommer att hantera vissa av dina personuppgifter om du väljer att prenumerera. Mer information om vår personuppgiftshantering finns här.
Beskrivning
Land | Sverige |
---|---|
Lista | First North Stockholm |
Sektor | Hälsovård |
Industri | Bioteknik |
2022-01-14 09:30:00
Nanexa AB (publ) today announced that the company has received a new patent in the USA. The newly issued patent (US 11,214,865 B2) relates to an ALD reactor adapted for large scale production of PharmaShell® coated drugs.
“This patent, which has already been granted in the UK (GB 2576851 B), is a good complement to our product and process patents for the drug delivery system PharmaShell®", says David Westberg, CEO of Nanexa.
ALD (Atomic Layer Deposition) is the chemical process Nanexa uses to produce the drug delivery platform PharmaShell®.